935
Views
120
CrossRef citations to date
0
Altmetric
Review Article

Immunity to Campylobacter: its role in risk assessment and epidemiology

, , , , , & show all
Pages 1-22 | Received 06 May 2008, Accepted 19 Nov 2008, Published online: 01 Feb 2009

References

  • Abuoun, M., Manning, G., Cawthraw, S.A., Ridley, A., Ahmed, I.H., Wassenaar, T.M., and Newell, D.G. 2005. Cytolethal distending toxin (CDT)-negative Campylobacter jejuni strains and anti-CDT neutralizing antibodies are induced during human infection but not during colonization in chickens. Infect Immun 73:3053–3062.
  • Adak, G.K., Cowden, J.M., Nicholas, S., and Evans, H.S. 1995. The Public Health Laboratory Service national case-control study of primary indigenous sporadic cases of campylobacter infection. Epidemiol Infect 115:15–22.
  • Aguas, R., Goncalves, G., and Gomes, M.G. 2006. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect Dis 6:112–117.
  • Al-Salloom, F.S., Al Mahmeed, A., Ismaeel, A., Botta, G.A., and Bakhiet, M. 2003. Campylobacter-stimulated INT407 cells produce dissociated cytokine profiles. J Infect 47:217–24.
  • Alm, R.A., Guerry, P., Power, M.E., Lior, H., and Trust, T.J. 1991. Analysis of the role of flagella in the heat-labile Lior serotyping scheme of thermophilic Campylobacters by mutant allele exchange. J Clin Microbiol 29:2438–2445.
  • Alm, R.A., Guerry, P., Power, M.E., and Trust, T.J. 1992. Variation in antigenicity and molecular weight of Campylobacter coli VC167 flagellin in different genetic backgrounds. J Bacteriol 174:4230–4238.
  • Andersen-Nissen, E., Smith, K.D., Strobe, K.L., Barrett, S.L., Cookson, B.T., Logan, S.M., and Aderem, A. 2005. Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci U S A 102:9247–9252.
  • Anderson, R.M., and May, R.M. 1991. Infectious diseases of humans – dynamics and control. Oxford: Oxford University Press.
  • Ang, C.W., Krogfelt, K., Herbrink, P., Keijser, J., van Pelt, W., Dalby, T., Kuijf, M., Jacobs, B.C., Bergman, M.P., Schiellerup, P., and Visser, C.E. 2007a. Validation of an ELISA for the diagnosis of recent Campylobacter infections in Guillain-Barre and reactive arthritis patients. Clin Microbiol Infect 13:915–922.
  • Ang, C.W., Van Pelt, W., Herbrink, P., Keijser, J., Van Duynhoven, Y.T.H.P., and Visser, C.E. 2007b. Sero-epidemiology indicates frequent and repeated exposure to Campylobacter during childhood. Zoon Pub Health 54 (Suppl. 1): 50.
  • Anonymous. 2000. Revised framework for microbial risk assessment. Washington DC: International Life Sciences Institute.
  • Anonymous. 2007. The Community Summary Report on Trends and Sources of Zoonoses, Zoonotic Agents, Antimicrobial Resistance and Foodborne Outbreaks in the European Union in 2006. The EFSA Journal 130:1–352.
  • Bacon, D.J., Alm, R.A., Burr, D.H., Hu, L., Kopecko, D.J., Ewing, C.P., Trust, T.J., and Guerry, P. 2000. Involvement of a plasmid in virulence of Campylobacter jejuni 81–176. Infect Immun 68, no. 8:4384–4390.
  • Bacon, D.J., Szymanski, C.M., Burr, D.H., Silver, R.P., Alm, R.A., and Guerry, P. 2001. A phase-variable capsule is involved in virulence of Campylobacter jejuni 81–176. Mol Microbiol 40:769–777.
  • Baker, M., Wilson, N., Ikram, R., Chambers, S., Shoemack, P., and Cook, G. 2006. Regulation of chicken contamination is urgently needed to control New Zealand’s serious campylobacteriosis epidemic. N Z Med J 119:U2264.
  • Bakhiet, M., Al-Salloom, F.S., Qareiballa, A., Bindayna, K., Farid, I., and Botta, G.A. 2004. Induction of alpha and beta chemokines by intestinal epithelial cells stimulated with Campylobacter jejuni. J Infect 48:236–244.
  • Baqar, S., Bourgeois, A.L., Applebee, L.A., Mourad, A.S., Kleinosky, M.T., Mohran, Z., and Murphy, J.R. 1996. Murine intranasal challenge model for the study of Campylobacter pathogenesis and immunity. Infect Immun 64:4933–39.
  • Baqar, S., Bourgeois, A.L., Schultheiss, P.J., Walker, R.I., Rollins, D.M., Haberberger, R.L., and Pavlovskis, O.R. 1995. Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates. Vaccine 13:22–28.
  • Baqar, S., Rice, B., Lee, L., Bourgeois, A.L., El Din, A.N., Tribble, D.R., Heresi, G.P., Mourad, A.S., and Murphy, J.R. 2001. Campylobacter jejuni enteritis. Clin Infect Dis 33:901–905.
  • Bar, W., Glenn-Calvo, E., and Krausse, R. 1991. Phagocytosis of enteric Campylobacter by human and murine granulocytes. FEMS Microbiol Immunol 3:143–149.
  • Belongia, E.A., Chyou, P.H., Greenlee, R.T., Perez-Perez, G., Bibb, W.F., and DeVries, E.O. 2003. Diarrhea incidence and farm-related risk factors for Escherichia coli O157:H7 and Campylobacter jejuni antibodies among rural children. J Infect Dis 187:1460–1468.
  • Bernatowska, E., Jose, P., Davies, H., Stephenson, M., and Webster, D. 1989. Interaction of Campylobacter species with antibody, complement and phagocytes. Gut 30:906–911.
  • Bhadra, R.K., Dutta, P., Bhattacharya, S.K., Dutta, S.K., Pal, S.C., and Nair, G.B. 1992. Campylobacter species as a cause of diarrhoea in children in Calcutta. J Infect 24:55–62.
  • Black, R.E., Perlman, D., Clements, M.L., Levine, M.M., and Blaser, M.J. 1992. Human volunteer studies with Campylobacter jejuni. In: Campylobacter jejuni: current status and future trends. eds. Nachamkin, I., Blaser, M.J., and Tompkins, L.S., 207–15. Washington DC: American Society for Microbiology.
  • Black Robert, E., Myron Levine, M., Mary Lou, Clements, Timothy Hughes, P., and Martin Blaser, J. 1988. Experimental Campylobacter jejuni infection in humans. J Infect Dis 157:472–479.
  • Blaser, M.J., 1997. Epidemiologic and clinical features of Campylo- bacter jejuni infections. J Infect Dis 176 Suppl 2:S103S105.
  • Blaser, M.J., Black, R.E., Duncan, D.J., and Amer, J. 1985. Campylobacter jejuni-specific serum antibodies are elevated in healthy Bangladeshi children. J Clin Microbiol 21:164–167.
  • Blaser, M.J., Hopkins, J.A., and Vasil, M.L. 1984. Campylobacter jejuni outer membrane proteins are antigenic for humans. Infect Immun 43:986–993.
  • Blaser, M.J., Sazie, E., and Williams, L.P., Jr., 1987. The influence of immunity on raw milk-associated Campylobacter infection. JAMA 257:43–46.
  • Blaser, M.J., Smith, P.F., and Kohler, P.F. 1985. Susceptibility of Campylobacter isolates to the bactericidal activity of human serum. J Infect Dis 151:227–35.
  • Blaser, M.J., Taylor, D.N., and Echeverria, P. 1986. Immune response to Campylobacter jejuni in a rural community in Thailand. J Infect Dis 153:249–254.
  • Borrmann, E., Berndt, A., Hanel, I., and Kohler, H. 2007. Campylobacter-induced interleukin-8 responses in human intestinal epithelial cells and primary intestinal chick cells. Vet Microbiol 124:115–24.
  • Byrd-Bredbenner, C., Abbot, J.M., Wheatley, V., Schaffner, D., Bruhn, C., and Blalock, L. 2008. Risky eating behaviors of young adults-implications for food safety education. J Am Diet Assoc 108:549–552.
  • Calva, J.J., Ruiz-Palacios, G.M., Lopez-Vidal, A.B., Ramos, A., and Bojalil, R. 1988. Cohort study of intestinal infection with campylobacter in Mexican children. Lancet 1, no. 8584:503–506.
  • Cawthraw, S.A., Feldman, R.A., Sayers, A.R., and Newell, D.G. 2002. Long-term antibody responses following human infection with Campylobacter jejuni. Clin Exp Immunol 130:101–106.
  • Cawthraw, S.A., Lind, L., Kaijser, B., and Newell, D.G. 2000. Antibodies, directed towards Campylobacter jejuni antigens, in sera from poultry abattoir workers. Clin Exp Immunol 122:55–60.
  • Chart, H., Frost, J.A., Oza, A., Thwaites, R., Gillanders, S., and Rowe, B. 1996. Heat-stable serotyping antigens expressed by strains of Campylobacter jejuni are probably capsular and not long-chain lipopolysaccharide. J Appl Bacteriol 81:635–640.
  • Chen, L., Geys, H., Cawthraw, S., Havelaar, A., and Teunis, P. 2006a. Dose response for infectivity of several strains of Campylobacter jejuni in chickens. Risk Anal 26:1613–1621.
  • Chen, M.L., Ge, Z., Fox, J.G., and Schauer, D.B. 2006b. Disruption of tight junctions and induction of proinflammatory cytokine responses in colonic epithelial cells by Campylobacter jejuni. Infect Immun 74:6581–6589.
  • Christenson, B., Ringner, A., Blucher, C., Billaudelle, H., Gundtoft, K.N., Eriksson, G., and Bottiger, M. 1983. An outbreak of campylobacter enteritis among the staff of a poultry abattoir in Sweden. Scand J Infect Dis 15:167–172.
  • Cordwell, S.J., Len, A.C., Touma, R.G., Scott, N.E., Falconer, L., Jones, D., Connolly, A., Crossett, B., and Djordjevic, S.P. 2008. Identification of membrane-associated proteins from Campylobacter jejuni strains using complementary proteomics technologies. Proteomics 8:122–139.
  • Cumberland, P., Sethi, D., Roderick, P.J., Wheeler, J.G., Cowden, J.M., Roberts, J.A., Rodrigues, L.C., Hudson, M.J., and Tompkins, D.S. 2003. The infectious intestinal disease study of England: a prospective evaluation of symptoms and health care use after an acute episode. Epidemiol Infect 130:453–160.
  • Dalpke, A., Frank, J., Peter, M., and Heeg, K. 2006. Activation of toll–like receptor 9 by DNA from different bacterial species. Infect Immun 74:940–946.
  • De Melker, H.E., and Conyn-van Spaendonck, M.A. 1998. Immunosurveillance and the evaluation of national immunization programmes: a population–based approach. Epidemiol Infect 121:637–643.
  • De Wit, M.A.S., Hoogenboom-Verdegaal, A.M.M., Goosen, E.S.M., Sprenger, M.J.W., and Borgdorff, M.W. 1996. Een bevolkingsonderzoek in vier regio’s in Nederland naar incidentie en ziektelast van gastroenteritis en van Campylobacteren Salmonella-infectie, Rapport nr. 149104014. Rijksinstituut voor Volksgezondheid en Milieu, Bilthoven.
  • De Wit, M.A.S., Koopmans, M.P.G., Kortbeek, L.M., Van Leeuwen, N.J., Bartelds, A.I.M., and Van Duynhoven, Y.T.H.P. 2001a. Gastroenteritis in sentinel general practices, The Netherlands. Emerg Infect Dis 7:82–91.
  • De Wit, M.A.S., Koopmans, M.P.G., Kortbeek, L.M., Wannet, W.J., Vinjé, J., Van Leusden, F., Bartelds, A.I.M., and van Duynhoven, Y.T.H.P. 2001b. Sensor, a population-based cohort study on gastroenteritis in the Netherlands: incidence and etiology. Am J Epidemiol 154:666–674.
  • Doorduyn, Y., Van Den Brandhof, W.E., Van Duynhoven, Y.T., Wannet, W.J., and Van Pelt, W. 2006. Risk factors for Salmonella Enteritidis and Typhimurium (DT104 and non-DT104) infections in The Netherlands: predominant roles for raw eggs in Enteritidis and sandboxes in Typhimurium infections. Epidemiol Infect 134:617–626.
  • Doorduyn, Y., Van Pelt, W., Siezen, C.L., Van der Horst, F., Van Duynhoven, Y.T., Hoebee, B., and Janssen, R. 2007. Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases. Epidemiol Infect 136:1–10.
  • Dubreuil, J.D., Kostrzynska, M., Logan, S.M., Harris, L.A., Austin, J.W., and Trust, T.J. 1990. Purification, characterization, and localization of a protein antigen shared by thermophilic campylobacters. J Clin Microbiol 28:1321–1328.
  • Eberhart-Phillips, J., Walker, N., Garrett, N., Bell, D., Sinclair, D., Rainger, W., and Bates, M. 1997. Campylobacteriosis in New Zealand: results of a case–control study. J Epidemiol Community Health 51:686–691.
  • Echeverria, P., Taylor, D.N., Lexsomboon, U., Bhaibulaya, M., Blacklow, N.R., Tamura, K., and Sakazaki, R. 1989. Case-control study of endemic diarrheal disease in Thai children. J Infect Dis 159:543–548.
  • Effler, P., Ieong, M.C., Kimura, A., Nakata, M., Burr, R., Cremer, E., and Slutsker, L. 2001. Sporadic Campylobacter jejuni infections in Hawaii: associations with prior antibiotic use and commercially prepared chicken. J Infect Dis 183:1152–1155.
  • Eisenberg, J.N., Seto, E.Y., Olivieri, A.W., and Spear, R.C. 1996. Quantifying water pathogen risk in an epidemiological framework. Risk Anal 16:549–563.
  • Ekdahl, K., and Andersson, Y. 2004. Regional risks and seasonality in travel-associated campylobacteriosis. BMC Infect Dis 4:54.
  • Ekdahl, K., and Giesecke, J. 2004. Travellers returning to Sweden as sentinels for comparative disease incidence in other European countries, campylobacter and giardia infection as examples. Euro Surveill 9:6–9.
  • Ellis, A., Irwin, R., Hockin, J., Borczyk, A., Woodward, D., and Johnson, W. 1995. Outbreak of Campylobacter infection among farm workers: an occupational hazard. Can Comm Dis Rep 21:153–156.
  • Ethelberg, S., Simonsen, J., Gerner-Smidt, P., Olsen, K.E., and Molbak, K. 2005. Spatial Distribution and Registry-based Case-Control Analysis of Campylobacter Infections in Denmark, 1991–2001. Am.J Epidemiol 162:1008–1015.
  • Evans, M.R., Roberts, R.J., Ribeiro, C.D., Gardner, D., and Kembrey, D. 1996. A milk-borne campylobacter outbreak following an educational farm visit. Epidemiol Infect 117:457–462.
  • Evers, E.G., Van Der Fels-Klerx, H.J., Nauta, M.J., Schijven, J.F., and Havelaar, A.H. 2008. Campylobacter source attribution by exposure assessment. Int J Risk Ass Mgt 8:174–190.
  • Fahey, T., Morgan, D., Gunneburg, C., Adak, G.K., Majid, F., and Kaczmarski, E. 1995. An outbreak of Campylobacter jejuni enteritis associated with failed milk pasteurisation. J Infect 31:137–143.
  • Fearnley, C., Manning, G., Bagnall, M., Javed, M.A., Wassenaar, T.M., and Newell, D.G. 2008. Identification of hyperinvasive Campylobacter jejuni strains isolated from poultry and human clinical sources. J Med Microbiol 57:570–580.
  • Fendler, C., Laitko, S., Sorensen, H., Gripenberg-Lerche, C., Groh, A., Uksila, J., Granfors, K., Braun, J., and Sieper, J. 2001. Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis 60:337–343.
  • Figueroa, G., Galeno, H., Troncoso, M., Toledo, S., and Soto, V. 1989. Prospective study of Campylobacter jejuni infection in Chilean infants evaluated by culture and serology. J Clin Microbiol 27:1040–1044.
  • Food Standards Agency. 2000. A report on the study of infectious intestinal disease in England. London: The Stationery Office.
  • Freeman, A.F., and Holland, S.M. 2007. Persistent bacterial infections and primary immune disorders. Curr Opin Microbiol 10:70–75.
  • Friedman, C.R., Neimann, J., Wegener, H.C., and Tauxe, R.V. 2000. Epidemiology of Campylobacter jejuni in the United States and other industrialized nations. In: Campylobacter. 2nd ed.eds. Nachamkin, I., and Blaser, M.J., 121–38. Washington, DC: ASM Press.
  • Gaudio, P.A., Echeverria, P., Hoge, C.W., Pitarangsi, C., and Goff, P. 1996. Diarrhea Among Expatriate Residents in Thailand: Correlation Between Reduced Campylobacter Prevalence and Longer Duration of Stay. J Travel Med 3:77–79.
  • Gaynor, E.C., Cawthraw, S., Manning, G., MacKichan, J.K., Falkow, S., and Newell, D.G. 2004. The genome-sequenced variant of Campylobacter jejuni NCTC 11168 and the original clonal clinical isolate differ markedly in colonization, gene expression, and virulence-associated phenotypes. J Bacteriol 186:503–517.
  • Georges-Courbot, M.C., Cassel-Beraud, A.M., Gouandjika, I., Monges, J., and Georges, A.J. 1990. A cohort study of enteric campylobacter infection in children from birth to two years in Bangui (Central African Republic). Trans R Soc Trop Med Hyg 84:122–125.
  • Gog, J.R., and Swinton, J. 2002. A status-based approach to multiple strain dynamics. J Math Biol 44:169–184.
  • Gomez-Escudero, O., Schmulson-Wasserman, M.J., and Valdovinos-Diaz, M.A. 2003. [Post-infectious irritable bowel syndrome. A review based on current evidence]. Rev Gastroenterol Mex 68:55–61.
  • Green, C.G., Krause, D., and Wylie, J. 2006. Spatial analysis of Campylobacter infection in the Canadian province of Manitoba. Int J Health Geogr 5:2.
  • Guarino, M., Casmiro, M. and D’Alessandro, R. 1998. Campylobacter jejuni infection and Guillain-Barre syndrome: a case-control study. Emilia-Romagna Study Group on Clinical and Epidemiological problems in neurology. Neuroepidemiol 17:296–302.
  • Guerry, P., Ewing, C.P., Hickey, T.E., Prendergast, M.M., and Moran, A.P. 2000. Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuni. Infect Immun 68:6656–6662.
  • Haas, C.N. 2002. Conditional dose-response relationships for microorganisms: development and application. Risk Anal 22:455–463.
  • Hao, Q., Saida, T., Kuroki, S., Nishimura, M., Nukina, M., Obayashi, H., and Saida, K. 1998. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barre syndrome with preceding Campylobacter jejuni and other identified infections. J Neuroimmunol 81:116–126.
  • Hasan, K.Z., Pathela, P., Alam, K., Podder, G., Faruque, S.M., Roy, E., Haque, A.K., Haque, R., Albert, M.J., Siddique, A.K., and Sack, R.B. 2006. Aetiology of diarrhoea in a birth cohort of children aged 0–2 year(s) in rural Mirzapur, Bangladesh. J Health Popul Nutr 24:25–35.
  • Havelaar, A.H. 2002. Campylobacteriose in Nederland: risico’s en interventiemogelijkheden, Rapport nr. 250911001. Rijksinstituur voor Volksgezondheid en Milieu, Bilthoven.
  • Havelaar, A.H., Vargas–Galindo, A´., Kurowicka, D., and Cooke, R.M. 2008. Attribution of Foodborne Pathogens Using Structured Expert Elicitation. Foodborne Pathog Dis 6:649–659.
  • Helms, M., Simonsen, J., and Molbak, K. 2006. Foodborne bacterial infection and hospitalization: a registry-based study. Clin Infect Dis 42:498–506.
  • Helms, M., Vastrup, P., Gerner-Smidt, P., and Molbak, K. 2003. Short and long term mortality associated with foodborne bacterial gastrointestinal infections: registry based study. BMJ 326:357.
  • Hickey, T.E., Majam, G., and Guerry, P. 2005. Intracellular survival of Campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin. Infect Immun 73:5194–5197.
  • Hickey, T.E., McVeigh, A.L., Scott, D.A., Michielutti, R.E., Bixby, A., Carroll, S.A., Bourgeois, A.L., and Guerry, P. 2000. Campylobacter jejuni cytolethal distending toxin mediates release of interleukin–8 from intestinal epithelial cells. Infect Immun 68:6535–6541.
  • Hill Gaston, J.S., and Lillicrap, M.S. 2003. Arthritis associated with enteric infection. Best Pract Res Clin Rheumatol 17:219–239.
  • Ho, T.W., Mishu, B., Li, C.Y., Gao, C.Y., Cornblath, D.R., Griffin, J.W., Asbury, A.K., Blaser, M.J., and McKhann, G.M. 1995. Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118(Pt 3):597–605.
  • Hoge, C.W., Shlim, D.R., Echeverria, P., Rajah, R., Herrmann, J.E., and Cross, J.H. 1996. Epidemiology of diarrhea among expatriate residents living in a highly endemic environment. JAMA 275:533–538.
  • Hoogenboom-Verdegaal, A.M.M., During, M., Engels, G.B., Hoogenveen, R.T., Hoekstra, J.A., Van Den Bosch, D.A., Kuyvenhoven, J.V.P.L., Mertens, J.M., and Smid, I.R.t. 1993. Bevolkingsonderzoek naar maag/darmklachten in vier regio’s van Nederland uitgevoerd in 1991. Deel 2: Onderzoek naar aanwezigheid van Salmonella en Campylobacter in faeces bij personen met en zonder maagdarmklachten in de bevolking., Rapport nr. 149101004. Rijksinstituut voor Volksgezondheid en Milieuhygie¨ne, Bilthoven.
  • Hu, L., Bray, M.D., Osorio, M., and Kopecko, D.J. 2006. Campylobacter jejuni induces maturation and cytokine production in human dendritic cells. Infect Immun 74:2697–2705.
  • Hu, L., and Hickey, T.E. 2005. Campylobacter jejuni induces secretion of proinflammatory chemokines from human intestinal epithelial cells. Infect Immun 73:4437–4440.
  • Huang, S., Sahin, O., and Zhang, Q. 2007. Infection-induced antibodies against the major outer membrane protein of Campylobacter jejuni mainly recognize conformational epitopes. FEMS Microbiol Lett 272:137–143.
  • Hughes, R.A., and Cornblath, D.R. 2005. Guillain-Barre syndrome. Lancet 366, no. 9497:1653–1666.
  • Jain, D., Sinha, S., Prasad, K.N., and Pandey, C.M. 2005. Campylobacter species and drug resistance in a north Indian rural community. Trans R Soc Trop Med Hyg 99:207–214.
  • Janssen, R., Krogfelt, K.A., Cawthraw, S.A., van Pelt, W., Wagenaar, J.A., and Owen, R.J. 2008. Host-pathogen interactions in Campylobacter infections: the host perspective. Clin Microbiol Rev 21:505–518.
  • Johanesen, P.A., and Dwinell, M.B. 2006. Flagellin-independent regulation of chemokine host defense in Campylobacter jejuni- infected intestinal epithelium. Infect Immun 74:3437–3447.
  • Johnsen, G., Kruse, H., and Hofshagen, M. 2007. Genotyping of thermotolerant Campylobacter from poultry slaughterhouse by amplified fragment length polymorphism. J Appl Microbiol 103:271–279.
  • Johnson, R.J., Nolan, C., Wang, S.P., Shelton, W.R., and Blaser, M.J. 1984. Persistent Campylobacter jejuni infection in an immunocompromised patient. Ann Intern Med 100:832–834.
  • Jones, D.M., Abbott, J.D., Eldridge, J., and Sutcliffe, E.M. 1981. Campylobacter serotyping and epidemiology. Lancet 1, no. 8216:386.
  • Jones, D.M., Eldridge, J., and Dale, B. 1980. Serological response to Campylobacter jejuni/coli infection. J Clin Pathol 33:767–769.
  • Jones, D.M., and Robinson, D.A. 1981. Occupational exposure to Campylobacter jejuni infection. Lancet 1, no. 8217:440–441.
  • Jones, D.M., Robinson, D.A., and Eldridge, J. 1981. Serological studies in two outbreaks of Campylobacter jejuni infection. J Hyg (Lond) 87:163–170.
  • Jones, F.R., Baqar, S., Gozalo, A., Nunez, G., Espinoza, N., Reyes, S.M., Salazar, M., Meza, R., Porter, C.K., and Walz, S.E. 2006. New World monkey Aotus nancymae as a model for Campylobacter jejuni infection and immunity. Infect Immun 74:790–793.
  • Kapperud, G., Espeland, G., Wahl, E., Walde, A., Herikstad, H., Gustavsen, S., Tveit, I., Natas, O., Bevanger, L., and Digranes, A. 2003. Factors associated with increased and decreased risk of Campylobacter infection: a prospective case-control study in Norway. Am J Epidemiol 158:234–242.
  • Karlinger, K., Gyorke, T., Mako, E., Mester, A., and Tarjan, Z. 2000. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol 35:154–167.
  • Karlyshev, A.V., Champion, O.L., Churcher, C., Brisson, J.R., Jarrell, H.C., Gilbert, M., Brochu, D., F. St Michael, J. Li, Wakarchuk, W.W., Goodhead, I., Sanders, M., Stevens, K., White, B., Parkhill, J., Wren, B.W., and Szymanski, C.M. 2005. Analysis of Campylobacter jejuni capsular loci reveals multiple mechanisms for the generation of structural diversity and the ability to form complex heptoses. Mol Microbiol 55:90–103.
  • Karmali, M.A., Kosoy, M., Newman, A., Tischler, M., and Penner, J.L. 1981. Reinfection with Campylobacter jejuni. Lancet, no. 8255: 1104.
  • Kiehlbauch, J.A., Albach, R.A., Baum, L.L., and Chang, K.P. 1985. Phagocytosis of Campylobacter jejuni and its intracellular survival in mononuclear phagocytes. Infect Immun 48:446–451.
  • Koga, M., Yuki, N., Takahashi, M., Saito, K., and Hirata, K. 1998. Close association of IgA anti–ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barre and Fisher’s syndromes. J Neuroimmunol 81:138–143.
  • Logan, S.M. 2006. Flagellar glycosylation – a new component of the motility repertoire? Microbiology 152, no. Pt 5:1249–1262.
  • Logan, S.M., and Trust, T.J. 1983. Molecular identification of surface protein antigens of Campylobacter jejuni. Infect Immun 42:675–682.
  • MacCallum, A.J., Harris, D., Haddock, G., and Everest, P.H. 2006. Campylobacter jejuni-infected human epithelial cell lines vary in their ability to secrete interleukin-8 compared to in vitro-infected primary human intestinal tissue. Microbiology 152:3661–3665.
  • Manaseki, S., Hawker, J., and Ali, S. 2004. Ethnic inequalities in campylobacter infection in Birmingham, UK: descriptive study of notified cases. J Epidemiol Community Health 58:278–279.
  • Mangen, M.-J.J., Havelaar, A.H., Bernsen, R.A.J.A.M., Van Koningsveld, R., and De Wit, G.A. 2005. The costs of human Campylobacter infections and sequelae in the Netherlands: A DALY and cost–of–illness approach. Acta Agriculturae Scandinavica, Section C – Economy 2:35–51.
  • Mansfield, L.S., Bell, J.A., Wilson, D.L., Murphy, A.J., Elsheikha, H.M., Rathinam, V.A., Fierro, B.R., Linz, J.E., and Young, V.B. 2007. C57BL/6 and congenic interleukin-10-deficient mice can serve as models of Campylobacter jejuni colonization and enteritis. Infect Immun 75:1099–1115.
  • Marshall, J.K., Thabane, M., Garg, A.X., Clark, W.F., Salvadori, M., and Collins, S.M. 2006. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterol 131:445–450.
  • Martin, P.M., Mathiot, J., Ipero, J., Kirimat, M., Georges, A.J., and Georges-Courbot, M.C. 1989. Immune response to Campylobacter jejuni and Campylobacter coli in a cohort of children from birth to 2 years of age. Infect Immun 57:2542–2546.
  • Mascart-Lemone, F.O., Duchateau, J.R., Oosterom, J., Butzler, J.P., and Delacroix, D.L. 1987. Kinetics of anti-Campylobacter jejuni monomeric and polymeric immunoglobulin A1 and A2 responses in serum during acute enteritis. J Clin Microbiol 25:1253–1257.
  • Mattila, L., Siitonen, A., Kyronseppa, H., Simula, I., Oksanen, P., Stenvik, M., Salo, P., and Peltola, H. 1992. Seasonal variation in etiology of travelers’ diarrhea. Finnish-Moroccan Study Group. J Infect Dis 165:385–388.
  • McBride, G.B., and French, N.P. 2006. Accounting for age-dependent susceptibility and occupation–dependent immune status: a new linear analytical SIR model. In: SMO 06 (Simulation, modelling and optimization)WSEAS (World Scientific and Engineering Academic Society).
  • McCarthy, N.D., Gillespie, I.A., Lawson, A.J., Cody, A.J., Neal, K.R., Hawtin, P.R., Owen, R.J., Maiden, M.C., and O’Brien, S.J.O. 2007. A three-year population based investigation of human Campylobacter jejuni epidemiology using sequence typing and patient survey data. Zoon Pub Health 54 (Suppl. 1):37.
  • McNally, D.J., Hui, J.P., Aubry, A.J., Mui, K.K., Guerry, P., Brisson, J.R., Logan, S.M., and Soo, E.C. 2006. Functional characterization of the flagellar glycosylation locus in Campylobacter jejuni 81–176 using a focused metabolomics approach. J Biol Chem 281:18489–18498.
  • Melamed, A., Zakuth, V., Schwartz, D., and Spirer, Z. 1988. The immune system response to Campylobacter infection. Microbiol Immunol 32:75–82.
  • Melamed, I., Bujanover, Y., Igra, Y.S., Schwartz, D., Zakuth, V., and Spirer, Z. 1983. Campylobacter enteritis in normal and immunodeficient children. Am J Dis Child 137:752–753.
  • Meynell, G.G., and Stocker, B.A.D. 1957. Some hypotheses on the aetiology of fatal infections in partially resistant hosts and their application to mice challenged with Salmonella paratyphi-B or Salmonella typhimurium by intraperitoneal injection. J Gen Microbiol 16:38–58.
  • Miller, G., Dunn, G.M., Reid, T.M., Ogden, I.D., and Strachan, N.J. 2005. Does age acquired immunity confer selective protection to common serotypes of Campylobacter jejuni? BMC Infect Dis 5:66.
  • Miller, G., Dunn, G.M., Smith-Palmer, A., Ogden, I.D., and Strachan, N.J. 2004. Human campylobacteriosis in Scotland: seasonality, regional trends and bursts of infection. Epidemiol Infect 132, no. 4:585–593.
  • Mills, S.D., and Bradbury, W.C. 1984. Human antibody response to outer membrane proteins of Campylobacter jejuni during infection. Infect Immun 43:739–743.
  • Mills, S.D., Kuzniar, B., Shames, B., Kurjanczyk, L.A., and Penner, J.L. 1992. Variation of the O antigen of Campylobacter jejuni in vivo. J Med Microbiol 36:215–219.
  • Molbak, K., Wested, N., Hojlyng, N., Scheutz, F., Gottschau, A., Aaby, P., and da Silva, A.P. 1994. The etiology of early childhood diarrhea: a community study from Guinea-Bissau. J Infect Dis 169:581–587.
  • Molina, J., Casin, I., Hausfater, P., Giretti, E., Welker, Y., Decazes, J., Garrait, V., Lagrange, P., and Modai, J. 1995. Campylobacter infections in HIV-infected patients: clinical and bacteriological features. AIDS 9:881–885.
  • Moran, A.P., and Penner, J.L. 1999. Serotyping of Campylobacter jejuni based on heat–stable antigens: relevance, molecular basis and implications in pathogenesis. J Appl Microbiol 86:361–377.
  • Morrow, A.L., Ruiz-Palacios, G.M., Jiang, X., and Newburg, D.S. 2005. Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. J Nutr 135:1304–1307.
  • Moxon, E.R., and Murphy, P.A. 1978. Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism. Proc Natl Acad Sci U S A 75:1534–1536.
  • Musher, D.M., and Musher, B.L. 2004. Contagious acute gastrointestinal infections. N Engl J Med 351:2417–2427.
  • Mäki-Ikola, O., Viljanen, M.K., Tiitinen, S., Toivanen, P., and Granfors, K. 1991. Antibodies to arthritis-associated microbes in inflammatory joint diseases. Rheumatol Int 10:231–234.
  • Nachamkin, I., Barbosa, P.A., Ung, H., Lobato, C., Rivera, A.G., Rodriguez, P., Briseno, A.G., Cordero, L.M., Perea, L.G., Perez, J.C., Ribera, M., Veitch, J., Fitzgerald, C., Cornblath, D., Pinto, M.R., Griffin, J.W., Willison, H.J., Asbury, A.K., and McKhann, G.M. 2007. Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurol 69:1665–1671.
  • Nachamkin, I., Fischer, S.H., Yang, X.H., Benitez, O., and Cravioto, A. 1994. Immunoglobulin A antibodies directed against Campylobacter jejuni flagellin present in breast-milk. Epidemiol Infect 112:359–565.
  • Nachamkin, I., and Hart, A.M. 1985. Western blot analysis of the human antibody response to Campylobacter jejuni cellular antigens during gastrointestinal infection. J Clin Microbiol 21:33–38.
  • Nachamkin, I., and Yang, X.H. 1989. Human antibody response to Campylobacter jejuni flagellin protein and a synthetic N-terminal flagellin peptide. J Clin Microbiol 27:2195–2198.
  • Nachamkin, I., and Yang, X.H. 1992. Local immune responses to the Campylobacter flagellin in acute Campylobacter gastrointestinal infection. J Clin Microbiol 30:509–511.
  • Neimann, J., Engberg, J., Molbak, K., and Wegener, H.C. 2003. A case-control study of risk factors for sporadic campylobacter infections in Denmark. Epidemiol Infect 130:353–366.
  • Newburg, D.S. 2005. Innate immunity and human milk. J Nutr 135:1308–1312.
  • Newell, D.G. 1986a. Monoclonal antibodies directed against the flagella of Campylobacter jejuni: production, characterization and lack of effect on the colonization of infant mice. J Hyg (Lond) 96:131–141.
  • Newell, D.G. 1986b. Monoclonal antibodies directed against the flagella of Campylobacter jejuni: cross-reacting and serotypic specificity and potential use in diagnosis. J Hyg (Lond) 96:377–384.
  • Newell, D.G., and Nachamkin, I. 1992. Immune responses directed against Campylobacter jejuni. In: Campylobacter jejuni: current status and future trends. eds. Martin, Irving Nachamkin, Blaser, J., and Lucy Tompkins, S. 201–206. Washington, DC: American Society for Microbiology.
  • Newman, A., and Lambert, J.R. 1980. Campylobacter jejuni causing flare-up in inflammatory bowel disease. Lancet 2, no. 8200: 919.
  • Nygard, K., Andersson, Y., Rottingen, J.A., Svensson, A., Lindback, J., Kistemann, T., and Giesecke, J. 2004. Association between environmental risk factors and campylobacter infections in Sweden. Epidemiol Infect 132:317–325.
  • Oberhelman, R.A., Gilman, R.H., Sheen, P., Cordova, J., Zimic, M., Cabrera, L., Meza, R., and Perez, J. 2006. An intervention-control study of corralling of free-ranging chickens to control Campylobacter infections among children in a Peruvian periurban shantytown. Am J Trop Med Hyg 74:1054–1059.
  • Panigrahi, P., Losonsky, G., DeTolla, L.J., and Morris, J.G., Jr. 1992. Human immune response to Campylobacter jejuni proteins expressed in vivo. Infect Immun 60:4938–4944.
  • Parkhill, J., Wren, B.W., Mungall, K., Ketley, J.M., Churcher, C., Basham, D., Chillingworth, T., Davies, R.M., Feltwell, T., Holroyd, S., Jagels, K., Karlyshev, A.V., Moule, S., Pallen, M.J., Penn, C.W., Quail, M.A., Rajandream, M.A., Rutherford, K.M., van Vliet, A.H., Whitehead, S., and Barrell, B.G. 2000. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 403:665–668.
  • Pei, Z.H., Ellison, R.T., 3rd, and Blaser, M.J. 1991. Identification, purification, and characterization of major antigenic proteins of Campylobacter jejuni. J Biol Chem 266:16363–16369.
  • Pennie, R.A., Pearson, R.D., Barrett, L.J., Lior, H., and Guerrant, R.L. 1986. Susceptibility of Campylobacter jejuni to strain-specific bactericidal activity in sera of infected patients. Infect Immun 52:702–706.
  • Perlman, D.M., Ampel, N.M., Schifman, R.B., Cohn, D.L., Patton, C.M., Aguirre, M.L., Wang, W.L., and Blaser, M.J. 1988. Persistent Campylobacter jejuni infections in patients infected with the human immunodeficiency virus (HIV). Ann. Intern. Med. 108:540–546.
  • Peterson, M.C. 2003. Campylobacter jejuni enteritis associated with consumption of raw milk. J Environ Health 65:20–21, 24, 26.
  • Pigrau, C., Bartolome, R., Almirante, B., Planes, A.M., Gavalda, J., and Pahissa, A. 1997. Bacteremia due to Campylobacter species: clinical findings and antimicrobial susceptibility patterns. Clin Infect Dis 25:1414–1420.
  • Pope, J.E., Krizova, A., Garg, A.X., Thiessen-Philbrook, H., and Ouimet, J.M. 2007. Campylobacter reactive arthritis: a systematic review. Semin Arthritis Rheum 37:48–55.
  • Porter, I.A., and Reid, T.M. 1980. A milk-borne outbreak of Campylobacter infection. J Hyg (Lond) 84:415–419.
  • Posch, J., Feierl, G., Wuest, G., Sixl, W., Schmidt, S., Haas, D., Reinthaler, F.F., and Marth, E. 2006. Transmission of Campylobacter spp. in a poultry slaughterhouse and genetic characterisation of the isolates by pulsed-field gel electrophoresis. Br Poult Sci 47:286–293.
  • Potter, R.C., Kaneene, J.B., and Hall, W.N. 2003. Risk factors for sporadic Campylobacter jejuni infections in rural michigan: a prospective case-control study. Am J Public Health 93:2118–2123.
  • Power, M.E., Alm, R.A., and Trust, T.J. 1992. Biochemical and antigenic properties of the Campylobacter flagellar hook protein. J Bacteriol 174:3874–3883.
  • Prendergast, M.M., Tribble, D.R., Baqar, S., Scott, D.A., Ferris, J.A., Walker, R.I., and Moran, A.P. 2004. In vivo phase variation and serologic response to lipooligosaccharide of Campylobacter jejuni in experimental human infection. Infect Immun 72:916–922.
  • Preston, M.A., and Penner, J.L. 1989. Characterization of cross-reacting serotypes of Campylobacter jejuni. Can J Microbiol 35:265–273.
  • Price, L.B., Roess, A., Graham, J.P., Baqar, S., Vailes, R., Sheikh, K.A., and Silbergeld, E. 2007. Neurologic symptoms and neuropathologic antibodies in poultry workers exposed to Campylobacter jejuni. J Occup Environ Med 49:748–755.
  • Rao, M.R., Naficy, A.B., Savarino, S.J., Abu–Elyazeed, R., Wierzba, T.F., Peruski, L.F., Abdel-Messih, I., Frenck, R., and Clemens, J.D. 2001. Pathogenicity and convalescent excretion of Campylobacter in rural Egyptian children. Am J Epidemiol 154:166–173.
  • Rautelin, H.I., and Kosunen, T.U. 1987. Campylobacter etiology in human gastroenteritis demonstrated by antibodies to acid extract antigen. J Clin Microbiol 25:1944–1951.
  • Renom, G., Kirimat, M., Georges, A.J., Philippe, J.C., and Martin, P.M. 1992. High levels of anti-Campylobacter-flagellin IgA antibodies in breast milk. Res Microbiol 143:93–98.
  • Riddle, M.S., Sanders, J.W., Putnam, S.D., and Tribble, D.R. 2006. Incidence, etiology, and impact of diarrhea among long-term travelers (US military and similar populations): a systematic review. Am J Trop Med Hyg 74:891–900.
  • Rothman, K.J., and Mahon, B.E. 2004. Confounding and effect-measure modification in the evaluation of immunogenic agents. Eur J Epidemiol 19:205–207.
  • Rubin, L.G. 1987. Bacterial colonization and infection resulting from multiplication of a single organism. Rev Infect Dis 9:488–493.
  • Ruiz-Palacios, G.M., Calva, J.J., Pickering, L.K., Lopez-Vidal, Y., Volkow, P., Pezzarossi, H., and West, M.S. 1990. Protection of breast–fed infants against Campylobacter diarrhea by antibodies in human milk. J Pediatr 116:707–713.
  • Saeed, A.M., Harris, N.V., and DiGiacomo, R.F. 1993. The role of exposure to animals in the etiology of Campylobacter jejuni/coli enteritis. Am J Epidemiol 137:108–114.
  • Samuel, M.C., Vugia, D.J., Shallow, S., Marcus, R., Segler, S., McGivern, T., Kassenborg, H., Reilly, K., Kennedy, M., Angulo, F., and Tauxe, R.V. 2004. Epidemiology of sporadic Campylobacter infection in the United States and declining trend in incidence, FoodNet 1996–1999. Clin Infect Dis 38 Suppl 3:S165–S174.
  • Schildt, M., Savolainen, S., and Hanninen, M.L. 2006. Long-lasting Campylobacter jejuni contamination of milk associated with gastrointestinal illness in a farming family. Epidemiol Infect 134:401–405.
  • Schmidt-Ott, R., Brass, F., Scholz, C., Werner, C., and Gross, U. 2005. Improved serodiagnosis of Campylobacter jejuni infections using recombinant antigens. J Med Microbiol 54:761–767.
  • Schmidt-Ott, R., Schmidt, H., Feldmann, S., Brass, F., Krone, B., and Gross, U. 2006. Improved serological diagnosis stresses the major role of Campylobacter jejuni in triggering Guillain-Barre syndrome. Clin Vaccine Immunol 13:779–783.
  • Schonheyder, H.C., Sogaard, P., and Frederiksen, W. 1995. A survey of Campylobacter bacteremia in three Danish counties, 1989 to 1994. Scand J Infect Dis 27:145–148.
  • Schwartz, D., Konforti, N., Perry, R., Goossens, H., Butzler, J.P., Williams, P., and Goldhar, J. 1994. Iron–regulated proteins in outer membranes of Campylobacter jejuni diarrhoea isolates and immune response to the proteins in patients. Zentralbl Bakteriol 280:338–347.
  • Shapiro, R.L., Lockman, S., Kim, S., Smeaton, L., Rahkola, J.T., Thior, I., Wester, C., Moffat, C., Arimi, P., Ndase, P., Asmelash, A., Stevens, L., Montano, M., Makhema, J., Essex, M., and Janoff, E.N. 2007. Infant morbidity, mortality, and breast milk immunologic profiles among breast-feeding HIV-infected and HIV-uninfected women in Botswana. J Infect Dis 196:562–569.
  • Sjögren, E., Ruiz-Palacios, G., and Kaijser, B. 1989. Campylobacter jejuni isolations from Mexican and Swedish patients, with repeated symptomatic and/or asymptomatic diarrhoea episodes. Epidemiol Infect 102:47–57.
  • Soderlin, M.K., Kautiainen, H., Puolakkainen, M., Hedman, K., Soderlund-Venermo, M., Skogh, T., and Leirisalo-Repo, M. 2003. Infections preceding early arthritis in southern Sweden: a prospective population-based study. J Rheumatol 30:459–464.
  • Strid, M.A., Engberg, J., Larsen, L.B., Begtrup, K., Molbak, K., and Krogfelt, K.A. 2001. Antibody responses to Campylobacter infections determined by an enzyme-linked immunosorbent assay: 2-year follow–up study of 210 patients. Clin Diagn Lab Immunol 8:314–319.
  • Studahl, A., and Andersson, Y. 2000. Risk factors for indigenous campylobacter infection: a Swedish case-control study. Epidemiol Infect 125:269–275.
  • Svedhem, A., and Kaijser, B. 1980. Campylobacter fetus subspecies jejuni: a common cause of diarrhea in Sweden. J Infect Dis 142:353–359.
  • Swift, L., and Hunter, P.R. 2004. What do negative associations between potential risk factors and illness in analytical epidemiological studies of infectious disease really mean? Eur J Epidemiol 19:219–223.
  • Talsma, E., Goettsch, W.G., Nieste, H.L., Schrijnemakers, P.M., and Sprenger, M.J. 1999. Resistance in Campylobacter species: increased resistance to fluoroquinolones and seasonal variation. Clin Infect Dis 29:845–848.
  • Tam, C.C., Higgins, C.D., Rodrigues, L.C., Owen, R.J., Richardson, J.F., Curnow, J., Lamden, K., Millership, S., Neal, K., Patel, B., Sheridan, P., Wren, B.W., Al-Jaberi, S., McCarthy, N., and O’Brien, S.J.O. 2007. Risk factors for reported Campylobacter enteritis in England: a case-control study. Zoon Publ Health 54 (Suppl. 1):2–3.
  • Taylor, B.V., Williamson, J., Luck, J., Coleman, D., Jones, D., and McGregor, A. 2004. Sensitivity and specificity of serology in determining recent acute Campylobacter infection. Intern Med J 34:250–258.
  • Taylor, D.N., Echeverria, P., Pitarangsi, C., Seriwatana, J., Bodhidatta, L., and Blaser, M.J. 1988. Influence of strain characteristics and immunity on the epidemiology of Campylobacter infections in Thailand. J Clin Microbiol 26:863–868.
  • Teunis, P., Van den Brandhof, W., Nauta, M., Wagenaar, J., Van den Kerkhof, H., and Van Pelt, W. 2005. A reconsideration of the Campylobacter dose-response relation. Epidemiol Infect 133:583–592.
  • Teunis, P.F.M., and Havelaar, A.H. 2000. The Beta-Poisson dose-response model is not a single-hit model. Risk Anal 20:513–520.
  • Teunis, P.F.M., Nagelkerke, N.J.D., and Haas, C.N. 1999. Dose response models for infectious gastroenteritis. Risk Anal 19:1251–1260.
  • Thibault, P., Logan, S.M., Kelly, J.F., Brisson, J.R., Ewing, C.P., Trust, T.J., and Guerry, P. 2001. Identification of the carbohydrate moieties and glycosylation motifs in Campylobacter jejuni flagellin. J Biol Chem 276:34862–34870.
  • Thompson, J.S., Cahoon, F.E., and Hodge, D.S. 1986. Rate of Campylobacter spp. isolation in three regions of Ontario, Canada, from 1978 to 1985. J Clin Microbiol 24:876–878.
  • Tompkins, D.S., Hudson, M.J., Smith, H.R., Eglin, R.P., Wheeler, J.G., Brett, M.M., Owen, R.J., Brazier, J.S., Cumberland, P., King, V., and Cook, P.E. 1999. A study of infectious intestinal disease in England: microbiological findings in cases and controls [see comments]. Commun Dis Public Health 2:108–113.
  • Torres, O., and Cruz, J.R. 1993. Protection against Campylobacter diarrhea: role of milk IgA antibodies against bacterial surface antigens. Acta Paediatr 82:835–38.
  • Tribble, D. 1998. “Suitability of experimental infections in volunteers to measure pathogenesis of foodborne pathogens.” Web page, [accessed 4 November 2005]. Available at http://www.foodriskclearinghouse.umd.edu/Aug1998/Talks/tribbletalk.htm.
  • Van den Brandhof, W.E., Bartelds, A.I., Koopmans, M.P., and Van Duynhoven, Y.T. 2006. General practitioner practices in requesting laboratory tests for patients with gastroenteritis in the Netherlands, 2001– 2002. BMC Fam Pract 7: 56.
  • van Koningsveld, R., Rico, R., Gerstenbluth, I., Schmitz, P.I., Ang, C.W., Merkies, I.S., Jacobs, B.C., Halabi, Y., Endtz, H.P., van der Meche, F.G., and van Doorn, P.A. 2001. Gastroenteritis-associated Guillain-Barre syndrome on the Caribbean island Curacao. Neurol 56:1467–1472.
  • Van Pelt, W., de Wit, M.A.S., Wannet, W.J.B., Ligtvoet, E.J.J., Widdowson, M.A., and van Duynhoven, Y.T.H.P. 2003. Laboratory surveillance of bacterial gastroenteric pathogens in The Netherlands, 1991– 2001. Epidemiol Infect 130:431–441.
  • Van Rhijn, I., Van den Berg, L.H., Ang, C.W., Admiraal, J., and Logtenberg, T. 2003. Expansion of human gammadelta T cells after in vitro stimulation with Campylobacter jejuni. Int Immunol 15:373–382.
  • Walan, A., Dahlgren, C., Kihlstrom, E., Stendahl, O., and Lock, R. 1992. Phagocyte killing of Campylobacter jejuni in relation to oxidative activation. APMIS 100:424–430.
  • Walz, S.E., Baqar, S., Beecham, H.J., Echeverria, P., Lebron, C., McCarthy, M., Kuschner, R., Bowling, S., Bourgeois, A.L., and Scott, D.A. 2001. Pre-exposure anti-Campylobacter jejuni immunoglobulin a levels associated with reduced risk of Campylobacter diarrhea in adults traveling to Thailand. Am J Trop Med Hyg 65:652–656.
  • Wassenaar, T.M., Engelskirchen, M., Park, S., and Lastovica, A. 1997. Differential uptake and killing potential of Campylobacter jejuni by human peripheral monocytes/macrophages. Med Microbiol Immunol 186:139–144.
  • Wassenaar, T.M., Kist, M., and de Jong, A. 2007. Re-analysis of the risks attributed to ciprofloxacin-resistant Campylobacter jejuni infections. Int. J. Antimicrob. Agents 30:195–201.
  • Watson, R.O., and Galan, J.E. 2005. Signal transduction in Campylobacter jejuni-induced cytokine production. Cell Microbiol 7:655–665.
  • Wenman, W.M., Chai, J., Louie, T.J., Goudreau, C., Lior, H., Newell, D.G., Pearson, A.D., and Taylor, D.E. 1985. Antigenic analysis of Campylobacter flagellar protein and other proteins. J Clin Microbiol 21:108–12.
  • Wheeler, J.G., Sethi, D., Cowden, J.M., Wall, P.G., Rodrigues, L.C., Tompkins, D.S., Hudson, M.J., and Roderick, P.J. 1999. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. BMJ 318, no. 7190:1046–1050.
  • Winsor, D.K.Jr., Mathewson, J.J., and DuPont, H.L. 1986. Western blot analysis of intestinal secretory immunoglobulin A response to Campylobacter jejuni antigens in patients with naturally acquired Campylobacter enteritis. Gastroenterol 90:1217–1222.
  • Yuki, N., and Koga, M. 2006. Bacterial infections in Guillain-Barre and Fisher syndromes. Curr Opin Neurol 19:451–57.
  • Zilbauer, M., Dorrell, N., Boughan, P.K., Harris, A., Wren, B.W., Klein, N.J., and Bajaj-Elliott, M. 2005. Intestinal innate immunity to Campylobacter jejuni results in induction of bactericidal human beta-defensins 2 and 3. Infect Immun 73:7281–7289.
  • Zwietering, M.H., and Havelaar, A.H. 2006. Dose-response relationships and foodborne disease. In: Food consumption and disease risk. ed. Potter, M. 422–439. Cambridge: Woodhead Publishing.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.